JPRN-UMIN000018215Recruiting未知
Study of the efficacy of hepatic arterial infusion therapy (modified Circadian chronotherapy) for unresectable colorectal cancer liver metastasis - Study of the efficacy of hepatic arterial infusion therapy (modified Circadian chronotherapy) for unresectable colorectal cancer liver metastasis
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 28
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient other than the above
Investigators
Similar Trials
Completed
Phase 1
Study on the safety of hepatic arterial infusion of cultured autologous bone marrow cells in patients with decompensated liver cirrhosisdecompensated liver cirrhosisJPRN-UMIN000035528Yamaguchi University Hospital5
Recruiting
Not Applicable
The efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced intrahepatic cholangiocarcinomaadvanced intrahepatic cholangiocarcinomaJPRN-UMIN000007303Iwate Medical University50
Completed
Phase 1
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28
Completed
Phase 2
Efficacy of postoperative hepatic arterial infusion chemotherapy with CDDP for hepatocellular carcioma with early recurrence risk factors.Hepatocellular carcinomaJPRN-UMIN000012041Department of Gastroenterology and Metabolism,Hiroshima University Hospital60
Completed
Not Applicable
Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinomaHepatocellular carcinoma (HCC)JPRN-UMIN000005678Department of Gastroenterology, Kanazawa University Hospital12
